Dr. Guy Sauvageau elected to the Academy of Science of the Royal Society of Canada
Published: Sep 11, 2018
MONTREAL, /CNW Telbec/ - Dr. Guy Sauvageau, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal and hematologist at the Maisonneuve-Rosemont Hospital (CIUSSS de l'Est-de-l'Île-de-Montréal), has been elected a member of the Academy of Science of the Royal Society of Canada (RSC).
A multidisciplinary commitment to cancer research
An honorary distinction
Research work providing hope
In collaboration with the team led by Anne Marinier, Principal Investigator and Director of Medicinal Chemistry at the IRIC, he discovered "UM171", a molecule that can multiply by 10 the number of hematopoietic stem cells present in a unit of umbilical cord blood. Combined with a technology facilitating the culture of stem cells owned by ExCellThera, the molecule was tested in a clinical study involving 25 leukemia patients. The results of Phases I and II of the clinical trial are promising and provide hope for the treatment of patients suffering from blood diseases.
Furthermore, in close collaboration with a pluridisciplinary team, Dr. Sauvageau manages the Leucegene project, a large-scale program based on developing diagnostic and prognostic tests as well as on identifying new therapeutic strategies for patients suffering from acute myeloid leukemia (AML). The characterization of the transcriptional and mutational landscape of hundreds of primary samples from patients suffering from AML resulted in better characterizing the various AML subgroups. Those same samples also underwent several chemical screens that resulted in identifying molecules with strong therapeutic potential.
"Guy Sauvageau is a credit to the teams that work together, on a daily basis at the IRIC, in fundamental, translational and applied research to fight cancer. By recognizing the scope of his work, the Royal Society of Canada is saluting his commitment to advances in research in the field of life sciences, for the benefit of Canadians", said Michel Bouvier, Chief Executive Officer of the IRIC.
About the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal
An ultra-modern research hub and training centre located in the heart of the Université de Montréal, the Institute for Research in Immunology and Cancer of the Université de Montréal was created in 2003 to shed light on the mechanisms of cancer and discover new, more effective therapies to counter this disease. The IRIC operates according to a model that is unique in Canada. Its innovative approach to research has already led to discoveries that will, over the coming years, have a significant impact on the fight against cancer. For more information: iric.ca
Virtual press kit : https://www.iric.ca/overview/#MN-00
About the Royal Society of Canada
Founded in 1882, the Royal Society of Canada (RSC) comprises the Academies of Arts, Humanities and Sciences of Canada. Its mission is to recognize scholarly, research and artistic excellence, to advise governments and organizations, and to promote a culture of knowledge and innovation in Canada and with other national academies around the world: www.rsc-src.ca
SOURCE Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal